RT Book, Section
A1 Labib, Angelina
A1 Rajabi-Estarabadi, Ali
A1 Nouri, Keyvan
A2 Nouri, Keyvan
SR Print(0)
ID 1194726163
T1 Skin Cancer in Transplant Patients
T2 Skin Cancer: A Comprehensive Guide
YR 2023
FD 2023
PB McGraw-Hill Education
PP New York, NY
SN 9781260453003
LK dermatology.mhmedical.com/content.aspx?aid=1194726163
RD 2023/09/22
AB SUMMARYAs  the  number  of  transplant  recipients  increases,  the  incidence  of  squamous  cell  carcinoma  (SCC),  basal  cell  carcinoma  (BCC),  melanoma,  Kaposi  sarcoma,  and  Merkel  cell  carcinoma  (MCC)  increases.SCC  causes  more  morbidity  and  mortality  in  transplant  recipients.Many  factors  play  a  role  in  the  development  and  nature  of  SCC,  including  sun  exposure,  infection  with  human  papillomavirus  (HPV),  and  immunosuppressive  drugs.Exploration  of  antirejection  drugs  has  revealed  both  direct  and  indirect  carcinogenesis  mechanisms  in  transplant  recipients.There  are  many  ways  to  treat  SCC  and  other  skin  lesions  in  transplant  patients,  including  excision,  destruction,  Mohs  surgery,  oral  retinoids,  and  reduction  of  immune  system  suppressants.There  is  an  increased  risk  of  reoccurrence  and  metastasis  in  this  subset  of  patients,  requiring  increased  medical  attention.